Evidence map›Paper›PMID 31810524›Full record

ReviewBrazilian journal of anesthesiology (Elsevier)

[Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications].

Javad Yazdani, Reza Khorshidi Khiavi, Mohammad Ali Ghavimi, Ali Mortazavi, Elahe Jabbari Hagh, Farzin Ahmadpour

Open access · diamondAbstract readReview
In one paragraph

Review in Brazilian journal of anesthesiology (Elsevier). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. The Development of Molecular Biology of Osteoporosis.International journal of molecular sciences · 2021
    Review
  13. Calcitonin: A useful old friend.Journal of musculoskeletal & neuronal interactions · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Javad YazdaniTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã.
Reza Khorshidi KhiaviTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã.
Mohammad Ali GhavimiTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã.
Ali MortazaviTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã.
Elahe Jabbari HaghTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã.
Farzin AhmadpourTabriz University of Medical Sciences, Department of Oral and Maxillofacial Surgery, Tabriz, Irã. Electronic address: phoenixinfirer@ymail.com.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesCalcitonin is a polypeptide hormone regulating the metabolism calcium in the body. For many years calcitonin has been used to maintain and improve bone mineral density and to reduce the fracture rate. Many studies showed that calcitonin had analgesic role in several painful circumstances. This pain-ameliorating effect is irrelevant to its osteoclastic inhibitory effect and mechanisms like altering Na+ channel and serotonin receptor expression or hypothesis including the endorphin-mediated mechanism were used to explain this effect. In this study we performed a thorough review on the role of calcitonin as an analgesic agent in different scenarios and investigated the fact that calcitonin can be a feasible medication to relieve pain.

methodMany studies focused on the analgesic effect of calcitonin in several painful circumstances, including acute pains related to vertebral fractures, metastasis, migraine and reflex sympathetic dystrophy as well as neuropathic pains related to spinal injuries or diabetes, and phantom pain. Also, calcitonin was showed to be a useful additive to local anesthesia in the case of controlling postoperative pain or trigeminal neuralgia more effectively. However we faced some contradictory data for conditions like lumbar canal stenosis, complex regional pain syndrome, phantom pain and malignancies.

conclusionThis study showed that calcitonin could be helpful analgesic agent in different painful situations. Calcitonin can be considered an eligible treatment for acute pains related to vertebral fractures and a feasible alternative for the treatment of the acute and chronic neuropathic pains where other medications might fail.

Indexed as

Acute PainAnalgesicsAnimalsCalcitoninChronic PainHumansNeuralgiaAnalgesicsCalcitoninAcute painCalcitoninCalcitoninaChronic painDiabetic neuropathiesDor agudaDor crônicaDor fantasmaEnxaquecaFraturas vertebraisMalignancyMalignidadeMigraineNeuropatias diabéticasPhantom painSpinal fractures

Identifiers

PMID31810524
PMCPMC9391842
OpenAlexW2981205848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.